Condition: Hurthle Cell Thyroid Cancer · Tall Cell Variant Thyroid Cancer · Follicular Thyroid Cancer · Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.
This description comes directly from the study's public registry record.
Padmasree Veeraraghavan, R.N. · (301) 451-7710 · padmasree.veeraraghavan@nih.gov
Joanna Klubo-Gwiezdzinska, M.D. · (301) 496-5052 · joanna.klubo-gwiezdzinska@nih.gov
Always discuss trial participation with your own doctor first.
| National Institutes of Health Clinical Center | Bethesda, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00001160